Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-031402

Options or other derivatives

  • Director acquired 48,917 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Bailey Webster Director 2026-06-30 Grant or award · Series D-1 Convertible Preferred Stock +48,917 207,535 D: show line 1 in the form
Loading xslF345X06/ownership.xml…